Summary
- Claude, Anthropic's AI model, spent 21 hours analyzing DNA databases, identifying a peculiar enzyme system dubbed ART.
- CRISPR co-inventor Feng Zhang expressed that the discovery is “genuinely intriguing.”
- However, CEO Dario Amodei noted that the system's exact function and potential usefulness are still uncertain.
In a recent press release, Anthropic revealed that its AI model, Claude, has uncovered a novel molecular machine within viral DNA. However, as CEO Dario Amodei pointed out, the "precise function, biotechnological utility (if any), or level of significance is not yet clear." In simpler terms, Claude has identified something new, but its purpose and importance remain ambiguous.
The discovery was made within bacteriophages, which are viruses that infect bacteria, located alongside a repeating DNA sequence that resembles a CRISPR array—a gene-editing tool that has revolutionized medical science. Anthropic has named this new finding ART, which stands for array-associated reverse transcriptases.
Reverse transcriptases are enzymes that convert RNA into DNA, a strategy utilized by various viruses and bacteria for their defense mechanisms. Claude analyzed over 200,000 of these enzymes, narrowing it down to 3,500 unusual candidates and finally selecting 20 for further examination.
This extensive search took 21 hours, utilizing approximately 950 AI agents working simultaneously, and processed about 210 million tokens, the units of text that the AI interprets during its analysis.
Amodei remarked, "At minimum, it is work I would have been proud to do as a PhD student." However, this claim has met with skepticism, as critics argue that no PhD student would feel proud to present a finding without understanding its significance or utility.
It’s unfortunate that Dario is aware of this. Having been a PhD student himself, he understands the significance of such results. If he had approached his advisor with a vague finding, it likely wouldn’t have been received well.
— Ravid Shwartz Ziv (@ziv_ravid) September 23, 2026
In simpler terms: this discovery raises questions about its nature and potential implications. A tweet by Min Choi highlighted Anthropic's announcement that Claude identified an unusual DNA sequence in bacteriophages.
— Tyler Lockton (@Tlockty) September 23, 2026
On the other hand, not all reactions have been negative. Feng Zhang, a prominent researcher in CRISPR technology from MIT and the Broad Institute, reviewed the findings and described them as "genuinely intriguing." He noted, "This is an exciting example of how AI agents can contribute to biological discovery."
Owen Lewis from the Techno-Optimist substack remarked on the significance of the process itself, stating that while Claude didn't conduct laboratory experiments, human scientists evaluated its hypotheses, selected the most promising candidates, and performed the necessary lab work.
That was quick. The probability of abundance is rising. Anthropic has released the first results from its new molecular biology lab, where scientists are utilizing Claude to explore extensive biological datasets and generate hypotheses.
— Owen Lewis (@is_OwenLewis) September 23, 2026
If ART proves to be beneficial, it could still take years before it impacts patients. Anthropic has not suggested otherwise, which is an important point to consider.
Nevertheless, Wall Street reacted swiftly, with shares of gene-editing firms such as CRISPR Therapeutics, Intellia Therapeutics, and Beam Therapeutics declining following the announcement.
This is not the first instance of Anthropic presenting findings that require careful interpretation. Earlier in July, the company claimed that Claude Mythos had solved a post-quantum cryptography problem that had stumped researchers for years.
That claim was later validated, but only after extensive human verification on a signature scheme that had never been implemented. This current discovery appears to be similarly noteworthy, yet also heavily qualified.
At present, what is confirmed is the existence of an unusual protein pattern, with one external scientist labeling it "intriguing," but there is no timeline established for determining its relevance. Anthropic has indicated that laboratory investigations are already in progress.
As always, they are.